Biotech Values

[poorgradstudent]

pymx:

The one red flag that I can come up with is that their efficiency is reduced by increasing ionic strength. They become weak at the physiological ionic strength of blood. So this could be one cause for concern.

Of course this type of nucleation and elongation / polymerization sequence can be "sped up" by increasing the concentration of the monomers, so perhaps the doses used will overcome this concern.